<![CDATA[Understanding the ERADICATE Trial Limitations and Key Takeaways]]>
The ERADICATE trial evaluating ceftobiprole in Staphylococcus aureus bacteremia provides important clinical insights, but like all studies, it has several key limitations that should be considered when applying its findings to practice. One major …